Circulating Inflammatory and Hemostatic Biomarkers Are Associated with All-Cause Death and Cancer Death in a Population of Community-Dwelling Japanese: the Tanushimaru Study

Overview

Journal Clin Med Insights Cardiol

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2015 Apr 30

PMID 25922585

Citations 4

Authors

Mika Enomoto

Hisashi Adachi

Ako Fukami

Ayako Yoshimura

Aya Obuchi

Sachiko Nakamura

Yume Nohara

Erika Nakao

Yoko Umeki

Kensuke Hori

Yoshihiro Fukumoto

Affiliations

Soon will be listed here.

Abstract

Background: In patients with cardiovascular diseases, inflammatory and hemostatic biomarkers are significant indicators of prognosis. We investigated whether circulating inflammatory and hemostatic biomarkers were predictive markers for all-cause death and cancer death in a population of community-dwelling Japanese.

Methods: We studied 1,920 healthy Japanese adults who underwent health examinations in 1999. Those who reported a history of inflammatory diseases and malignancy on a baseline questionnaire were excluded. Inflammatory and hemostatic biomarkers were measured in the remaining 1,862 participants, who were followed up periodically for 10 years. Multivariate proportional hazards regression analysis was used to estimate all-cause and cancer mortality.

Results: A total of 258 participants died during follow-up: 87 from cancer, 38 from cerebro-cardiovascular diseases, and 133 from other diseases. Mean C-reactive protein (CRP) levels at baseline were significantly higher in decedents than in survivors. Mean von Willebrand factor (vWF) levels at baseline were significantly higher in decedents than in survivors. The Cox proportional hazards model after adjustments for age and sex showed that CRP (hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.06-1.51) and vWF (HR, 1.01; 95% CI, 1.00-1.01) were independent predictors of all-cause death. CRP (HR, 1.40; 95% CI, 1.06-1.86) and vWF (HR, 1.01; 95% CI, 1.00-1.02) were also independent predictive markers for cancer death.

Conclusions: Serum CRP and vWF were predictors of all-cause death and cancer death in the population of community dwelling Japanese.

Citing Articles

Effect of far-infrared radiation therapy on von Willebrand factor in patients with chronic kidney disease.

Yen C, Hsu P, Lin C, Chen S, Hsiao C, Hwang S Front Med (Lausanne). 2023; 10:1268212.

PMID: 37746066 PMC: 10514495. DOI: 10.3389/fmed.2023.1268212.

Prognostic value of von Willebrand factor in patients with atrial fibrillation: A meta-analysis.

Zhong C, Xin M, He L, Sun G, Shen F Medicine (Baltimore). 2018; 97(27):e11269.

PMID: 29979393 PMC: 6076195. DOI: 10.1097/MD.0000000000011269.

High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men.

Orwoll E, Wiedrick J, Jacobs J, Baker E, Piehowski P, Petyuk V Aging Cell. 2018; 17(2).

PMID: 29399943 PMC: 5847880. DOI: 10.1111/acel.12717.

Inflammation, Atherosclerosis and Coronary Artery Disease.

Momiyama Y, Adachi H, Fairweather D, Ishizaka N, Saita E Clin Med Insights Cardiol. 2016; 8(Suppl 3):67-70.

PMID: 27594791 PMC: 5003124. DOI: 10.4137/CMC.S39423.

References

Anderson S, Hutchings D, Heald A, Anderson C, Sanders T, Cruickshank J . Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European origin. Atherosclerosis. 2014; 236(1):62-72. DOI: 10.1016/j.atherosclerosis.2014.06.004. View

OByrne K, Dalgleish A . Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001; 85(4):473-83. PMC: 2364095. DOI: 10.1054/bjoc.2001.1943. View

Declerck P, Alessi M, Verstreken M, Kruithof E, Juhan-Vague I, Collen D . Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988; 71(1):220-5. View

Hirai Y, Geleijnse J, Adachi H, Imaizumi T, Kromhout D . Systolic blood pressure predicts cardiovascular mortality in a farming but not in a fishing community. -A 40-year follow up of the Japanese cohorts of the seven countries study-. Circ J. 2011; 75(8):1890-6. DOI: 10.1253/circj.cj-10-0971. View

Terraube V, Marx I, Denis C . Role of von Willebrand factor in tumor metastasis. Thromb Res. 2007; 120 Suppl 2:S64-70. DOI: 10.1016/S0049-3848(07)70132-9. View

Poole C, Conway P, Currie C . An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology (Oxford). 2008; 48(1):78-82. DOI: 10.1093/rheumatology/ken415. View

Lobo S, Lobo F, Bota D, Lopes-Ferreira F, Soliman H, Melot C . C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003; 123(6):2043-9. DOI: 10.1378/chest.123.6.2043. View

Koenig W, Khuseyinova N, Baumert J, Meisinger C . Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem. 2007; 54(2):335-42. DOI: 10.1373/clinchem.2007.100271. View

Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K . C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study. Atherosclerosis. 2002; 160(2):433-40. DOI: 10.1016/s0021-9150(01)00595-0. View

10.

Rallidis L, Vikelis M, Panagiotakos D, Liakos G, Krania E, Kremastinos D . Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients. Acta Neurol Scand. 2007; 117(6):415-20. DOI: 10.1111/j.1600-0404.2007.00971.x. View

11.

Shankar A, Wang J, Rochtchina E, Yu M, Kefford R, Mitchell P . Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med. 2006; 166(2):188-94. DOI: 10.1001/archinte.166.2.188. View

12.

Wanner C, Metzger T . C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant. 2002; 17 Suppl 8:29-32; discussion 39-40. DOI: 10.1093/ndt/17.suppl_8.29. View

13.

Jug B, Guzic Salobir B, Vene N, Sebestjen M, Sabovic M, Keber I . Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels. 2009; 24(4):271-6. DOI: 10.1007/s00380-008-1111-4. View

14.

Erlinger T, Muntner P, Helzlsouer K . WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev. 2004; 13(6):1052-6. View

15.

Lip G, Blann A . von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?. Cardiovasc Res. 1997; 34(2):255-65. DOI: 10.1016/s0008-6363(97)00039-4. View

16.

Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A . C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis. 2009; 207(1):291-7. DOI: 10.1016/j.atherosclerosis.2009.04.020. View

17.

Alley D, Crimmins E, Bandeen-Roche K, Guralnik J, Ferrucci L . Three-year change in inflammatory markers in elderly people and mortality: the Invecchiare in Chianti study. J Am Geriatr Soc. 2007; 55(11):1801-7. PMC: 2646097. DOI: 10.1111/j.1532-5415.2007.01390.x. View

18.

Wang W, Lin J, Lin T, Chiou T, Liu J, Yen C . Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma. World J Gastroenterol. 2005; 11(14):2166-70. PMC: 4305789. DOI: 10.3748/wjg.v11.i14.2166. View

19.

Golino P, Cirillo P, Calabro P, Ragni M, dAndrea D, Avvedimento E . Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries. J Am Coll Cardiol. 2001; 38(2):569-76. DOI: 10.1016/s0735-1097(01)01350-x. View

20.

Jefferis B, Whincup P, Lennon L, Papacosta O, Wannamethee S . Physical activity in older men: longitudinal associations with inflammatory and hemostatic biomarkers, N-terminal pro-brain natriuretic peptide, and onset of coronary heart disease and mortality. J Am Geriatr Soc. 2014; 62(4):599-606. PMC: 4283726. DOI: 10.1111/jgs.12748. View